Data Analytics has been revolutionizing the healthcare industry, particularly in the realms of pharmaceuticals, medical devices, and biotechnology. This transformation is evident in the advancements made by companies in these sectors, with Data Analytics playing a pivotal role in their success. For instance, the commercialization of new drugs, traditionally a process spanning over 10 to 15 years, is being significantly expedited through the integration of Data Analytics. This innovative approach can reduce development time by streamlining research, optimizing clinical trials, and enhancing decision-making processes.
While Pharmaceutical and Pharma research companies generally employ hundreds of Pharmaceutical scientists who work across Drug Discovery, Drug Development and Compliance, an equally important role is held by Technical Consultants who serve at the intersection of Pharmaceutical Innovation and Business leadership. Consultants in technical and leadership roles are crucial in companies, offering specialized knowledge and an objective perspective that drives strategic planning and decision-making. They are adept at identifying and solving specific problems, leveraging their technical acumen to analyze data and devise effective solutions. Their strong leadership skills are key in managing change and guiding organizations through transitions with minimal disruption. Additionally, they play a significant role in training and development, enhancing employee capabilities to meet current and future challenges. Highlighting one such prominent leader – Ms. Wajiha Ali, who currently works at IQVIA, an expert making groundbreaking contributions in hematology, a field focusing on blood-related diseases and cancers.
Ms. Wajiha Ali serves as a Principal Consultant at the Fortune 300 company, which is acclaimed for its advanced analytics, technology solutions, and contract research services in the life sciences industry. IQVIA is at the forefront of research in areas such as personalized medicine and real-world evidence, setting new standards in the industry. As a consultant, Ms. Ali stands at the intersection of business and drug development, where her unique expertise is propelling the company forward. Her leadership skills, honed through an MBA from INSEAD, play a critical role in her current position, enabling her to integrate business acumen with scientific knowledge for impactful results.
Ms. Ali’s professional journey is marked by significant contributions to hematology, focusing on blood-related diseases and cancers. Her expertise in this field has been vital in supporting developers of cell therapies, gene therapies, antibodies, and antibody-drug conjugates. Her strategic insights have been instrumental in the development and commercialization of leading medications and in advancing treatments in the developmental pipeline.
Her career spans over 15 years, during which Ms. Ali has been a founding member of a renowned analytics and consulting firm, a partner to leading healthcare organizations, and a mentor and advisor to burgeoning startups. Her work, which has been utilized by over 30 pharmaceutical, biotech, and device companies, including those ranked within the Fortune 100, demonstrates the depth and breadth of her impact in the industry.
A highlight of Ms. Ali’s career was her foundational role at Axiom Healthcare Strategies, a prestigious think tank headquartered in Princeton, NJ. At Axiom, she played a pivotal role in the company’s exponential growth and was instrumental in securing six of the top 15 pharmaceutical and biotech companies as clients.
Her leadership in hematology and multiple myeloma initiatives at Axiom have been particularly noteworthy in achieving these outcomes.
In addition to her corporate endeavors, Ms. Ali has been actively involved in consulting, advising, and mentoring various growing companies and startups since 2015. Her advisory support, judgment, and mentorship roles have been widely recognized, including her involvement with mHUB, an award-winning, government-supported innovation center in Chicago, where she mentors startups specializing in hematology diseases.
Ms. Ali’s academic background includes a bachelor’s degree in pharmacy, a research-based master’s degree (MS) in pharmaceutical sciences, and an MBA from INSEAD. Her acceptance into INSEAD’s highly competitive MBA program in 2022 underscores her academic and professional excellence.
Published by: Martin De Juan